TheProfitWatch

TCRT - Alaunos Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.47 -0.27 (-7.78%) --- --- -0.05 (-1.54%) -0.1 (-2.88%) -0.23 (-6.71%) 0.0 (0.01%) -0.18 (-5.08%)

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.63
Diluted EPS:
-0.63
Basic P/E:
-5.0794
Diluted P/E:
-5.0794
RSI(14) 1m:
10.0
VWAP:
3.2
RVol:

Events

Period Kind Movement Occurred At

Related News